Continuous glucose monitoring may lower mortality risk in diabetic patients on insulin

People with type 2 diabetes (T2D) who began using continuous glucose monitoring (CGM) while receiving basal insulin had a 44% lower risk of dying from any cause after one year than those who did not use CGM, according to an analysis of patient data being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2. After two years, their risk was 35% lower.

Read it at Medical Xpress ↗

← Front page